Total Return chart Amplia Therapeutics Limited

Stocks

Market Closed - Australian S.E. 07:10:08 29/09/2026 BST			5-day change	1st Jan Change
0.1150 ^AUD	-4.17%		-8.00%	-23.33%

09-15	Amplia Therapeutics, ANZGOG Finalize Protocol for Phase Two Ovarian Cancer Trial; Shares Up 4%	MT
08-04	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.